Age (65≥/65<)
|
1.0869
|
0.56–2.08
|
0.8012
|
–
|
–
|
–
|
1.2365
|
0.60–2.50
|
0.5563
|
–
|
–
|
–
|
Gender (male/female)
|
0.7341
|
0.33–1.61
|
0.4403
|
–
|
–
|
–
|
1.2665
|
0.45–3.49
|
0.6482
|
–
|
–
|
–
|
Pathological Stage (I/II-III)
|
1.7621
|
1.08–2.87
|
0.0232
|
1.1665
|
0.64–2.10
|
0.6097
|
2.4598
|
1.49–4.06
|
0.0004
|
2.0609
|
1.19–3.56
|
0.0096
|
Pathologic T (1/2–4)
|
2.0430
|
1.15–3.60
|
0.0134
|
2.4608
|
1.28–4.70
|
0.0065
|
1.7041
|
0.98–2.95
|
0.0576
|
–
|
–
|
–
|
Vascular Invasion (present/absent)
|
0.6360
|
0.38–1.04
|
0.0722
|
–
|
–
|
–
|
0.6629
|
0.40–1.09
|
0.1104
|
–
|
–
|
–
|
Lymphatic permeation (present/absent)
|
1.7469
|
1.06–2.86
|
0.0267
|
1.5167
|
0.88–2.61
|
0.1331
|
2.7949
|
1.64–4.74
|
0.0001
|
2.1239
|
1.19–3.76
|
0.0098
|
VEGFR2 protein expression (high/low)
|
3.2560
|
1.94–5.45
|
< 0.0001
|
3.4920
|
2.01–6.05
|
< 0.0001
|
2.0079
|
1.20–3.34
|
0.0073
|
2.1163
|
1.24–3.60
|
0.0059
|
TUBB3 protein expression (high/low)
|
1.3197
|
0.79–2.18
|
0.2787
|
–
|
–
|
–
|
1.5876
|
0.95–2.65
|
0.0769
|
–
|
–
|
–
|
STMN1 protein expression (high/low)
|
1.3547
|
0.80–2.26
|
0.2473
|
–
|
–
|
–
|
1.0824
|
0.65–1.80
|
0.7605
|
–
|
–
|
–
|
STXBP4 protein expression (Pos/Neg)
|
2.5395
|
1.40–4.60
|
0.0021
|
1.4777
|
0.79–2.75
|
0.2186
|
1.8387
|
1.02–3.29
|
0.0405
|
1.4788
|
0.81–2.69
|
0.2013
|
∆Np63 protein expression (Pos/Neg)
|
2.0070
|
1.15–3.48
|
0.0134
|
1.8673
|
1.05–3.30
|
0.0324
|
1.2518
|
0.74–2.11
|
0.4007
|
–
|
–
|
–
|
p53 protein expression (Pos/Neg)
|
0.8030
|
0.49–1.31
|
0.3805
|
–
|
–
|
–
|
0.8854
|
0.53–1.46
|
0.6335
|
–
|
–
|
–
|
PD-L1 protein expression (Pos/Neg)
|
1.0638
|
0.63–1.77
|
0.8117
|
–
|
–
|
–
|
1.1789
|
0.69–1.99
|
0.5398
|
–
|
–
|
–
|